Choose a country to view content specific to your location

Lyo-Ready Direct RNA NASBA Saliva

RT-qPCR became the standard for RNA detection because of widely available reagents and standardized workflows. Now you can unlock the advantages of isothermal RNA amplification without the complexity of developing Nucleic Acid Sequence-Based Amplification (NASBA) formulations in-house. Lyo-Ready Direct RNA NASBA Saliva is a glycerol-free, lyophilization-ready NASBA mix designed for sensitive one-step RNA amplification directly from saliva and sputum at 41 °C, eliminating the need for thermal cycling or thermal denaturation. Lyo-Ready Direct RNA NASBA Saliva can be used wet or lyophilized, enabling transition from liquid assay development to ambient-stable point-of-care formats without reformulating.

Have questions about a product?

Contact us to learn more about Meridian’s molecular or immunoassay reagent portfolio. We want to hear from you!

Key Product Features

  • Streamline Workflow: A one-step, single-tube solution combines all components into a pre-prepared mix, operating efficiently at 41 °C.

  • Improved Usability: Reduces hands-on time by up to 50%, boosting workflow efficienc.

  • Rapid Result: Delivers fast isothermal RNA amplification without thermal cycling.

  • Optimized for Point-of-Care (POC) Diagnostics: Ideal for integration into low-cost, portable diagnostic devices for POC us.

Specificity in saliva, sputum, UTM and VTM

Bar chart of time-to-result (ITR in minutes) showing comparisons for SARS-CoV-2, Influenza A, and Saliva 2. For each target, bars labeled liquid (blue), lyo (red), and NTC (black) across multiple conditions, with Y-axis from 0 to 60 minutes and error bars.

Lyo-Ready Direct RNA NASBA Saliva (MDX221) was examined using SARS-CoV2 RNA in 20% UTM, 20% VTM and 10% sputum and Influenza A RNA in 10% UTM, 10% VTM and 2% saliva in both liquid (blue) and lyophilized formats (red). Reactions were incubated at 41°C for 60 minutes. Error bars represent the standard deviation across three technical replicates. Lyo-Ready Direct RNA NASBA Saliva provides fast results, high-specificity and reproducibility to give the same accurate results from both saliva and sputum derived samples in both liquid and lyophilized formats.

Description

Lyo-Ready Direct RNA NASBA Saliva (MDX221) is a glycerol-free, lyophilization-ready master mix developed for rapid RNA detection from saliva and sputum using NASBA. In contrast to conventional NASBA protocols, which require a pre-denaturation step at 65 °C to prepare RNA and primers, Lyo-Ready Direct RNA NASBA Saliva streamlines the process into a single-pot, one-step NASBA procedure without the need for thermal denaturation. Additionally, its glycerol-free, lyo-excipient-enhanced formulation supports freeze-drying, simplifying the development of ambient-temperature stable assays that are particularly well-suited for point-of-care (POC) saliva and sputum testing.

Saliva has become an increasingly important specimen for molecular diagnostics because it enables simple, non-invasive sample collection and is well suited to decentralized and point-of-care testing. Isothermal amplification, with its simplified equipment requirements and single-temperature incubation, is ideally suited for these applications. Moreover, POC solutions address the inherent instability of RNA, as delays between sampling and testing can significantly impact assay reliability. By enabling near-patient diagnostics, POC workflows enable faster testing while helping preserve RNA integrity by minimizing delays between collection and analysis.

Lyo-Ready Direct RNA NASBA Saliva is specifically designed to meet these needs. It offers high inhibitor tolerance and rapid isothermal amplification for sensitive RNA detection in minimally processed saliva or sputum. The mix effectively overcomes the high inhibitor concentrations typically found in saliva and sputum, delivering reproducibility and fast reaction kinetics for rapid results, even at lower incubation temperatures.

 Key Points

  • High Sensitivity: Detects RNA from both minimally processed and purified saliva and sputum samples.
  • Simplified workflow: One-step process requiring only the addition of primers and molecular beacons, eliminating the need for a denaturation step
  • Reduced Assay Development Time: Pre-optimized master mix for rapid deployment.
  • Point-of-Care Ready: Lyo-ready for ambient-temperature stable assays, eliminating cold-chain dependence.

Lyo-Ready Direct RNA NASBA Saliva, MDX221

Application: NASBASpecimen Type: Saliva, Sputum, RNAConcentration: 2.5xHigh Concentration: YesWet: YesGlycerol-Free: YesLyo-Ready: YesAir-Dryable: YesDryable: Lyo-ReadySustainability: Lyophilizable

Single pot, one-step Nucleic Acid Sequence-Based Amplification (NASBA) for reliable isothermal amplification of RNA transcripts from crude or purified saliva samples, ideal for POC testing

Available in 50 reaction (400 µL) and 250 (2 mL) reaction aliquots

Catalogs & Brochures

Reagent Solutions for Molecular Diagnostics
Reagent Solutions for Molecular Diagnostics
Catalog

FAQs: Lyo-Ready Direct RNA NASBA Saliva

What enzymes are used in the NASBA mix?

Three enzymes are used in the NASBA mix: reverse transcriptase, RNase H and RNA polymerase. The RT enzyme synthesizes the complementary DNA strand of a given RNA using one of the primers included in the reaction. RNase H removes the RNA template from RNA-DNA hybrid to allow binding of the second primer to cDNA, producing double-stranded DNA by RT enzyme. Afterward, the polymerase transcribes the double-stranded DNA to copy the RNA target.

NASBA is isothermal (amplification of the RNA is usually carried out at 41°C), so it does not require thermal cycling, which simplifies the equipment and reduces the risk of temperature-related errors. It is specifically designed for RNA targets, making it highly suitable for detecting RNA viruses and mRNA. NASBA amplifies RNA rapidly with high sensitivity, making it useful for applications requiring quick results.​

The requirement for multiple enzymes and specific reaction conditions can make NASBA more complex to set up compared to some other methods, to overcome these difficulties, and to make this technology more accessible, we developed the NASBA mixes, which are pre-optimized and ready-to-use The design of primers must also be highly specific to the target RNA to avoid non-specific amplification and one of the primers must include a T7 promoter sequence for RNA transcription by T7 RNA polymerase.

NASBA is primarily designed for RNA amplification. However, DNA targets can be indirectly detected if they are first transcribed into RNA using an additional transcription step.

NASBA has been used in medical diagnostics from urine, to detect RNA viruses such as Chikungunya Virus, Hepatitis C Virus, West Nile Virus, Zika Virus and Yellow Fever Virus.

Learn More About Us